Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum

Molecules

Volumn 18, Issue 8, 2013, Pages 9163-9178

  Wang, Wen Long ^a,b   Song, Li Jun ^c   Chen, Xia ^a   Yin, Xu Ren ^c   Fan, Wen Hua ^b   Wang, Gu Ping ^a   Yu, Chuan Xin ^c   Feng, Bainian ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b Jiangshu Alpha Biopharmaceuticals Inc   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Antischistosomal activity; Neglected tropical disease; Praziquantel derivatives; Schistosoma japonicum

Indexed keywords

ANTISCHISTOSOMAL AGENT; DRUG DERIVATIVE; PRAZIQUANTEL;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; DRUG EFFECT; PARASITOLOGY; PATHOGENICITY; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; STRUCTURE ACTIVITY RELATION; SYNTHESIS; ANALOGS AND DERIVATIVES; DRUG EFFECTS;

ANIMALS; MOLECULAR STRUCTURE; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SCHISTOSOMICIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84883174629     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18089163     Document Type: Article

References (36)

1. Danso-Appiah, A.; Olliaro, P.L.; Donegan, S.; Sinclair, D.; Utzinger, J. Drugs for treating Schistosoma mansoni infection. Cochrane. Database. Syst. Rev. 2013, 2, CD000528.
2. Gryseels, B.; Polman, K.; Clerinx, J.; Kestens, L. Human schistosomiasis. Lancet 2006, 368, 1106-1118.
3. Zheng, H.; Zhang, L.J.; Zhu, R.; Xu, J.; Li, S.Z.; Guo, J.G.; Xiao, N.; Zhou, X.N. Schistosomiasis situation in People's Republic of China in 2011. Chin. J. Schisto. Control. 2012, 24, 621-626.
4. Caffrey, C.R.; Secor, W.E. Schistosomiasis: From drug deployment to drug development. Curr. Opin. Infect. Dis. 2011, 24, 410-417.
5. Stelma, F.F.; Talla, I.; Sow, S.; Kongs, A.; Niang, M.; Polman, K.; Deelder, A.M.; Gryseels, B. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1995, 53, 167-170.
6. Wang, W.; Wang, L.; Liang, Y.S. Susceptibility or resistance of praziquantel in human schistosomiasis: a Review. Parasitol. Res. 2012, 111, 1871-1877.
7. Caixeta, S.C.; Magalhaes, L.G.; de Melo, N.I.; Wakabayashi, K.A.; Aguiar Gde, P.; Aguiar Dde, P.; Mantovani, A.L.; Alves, J.M.; Oliveira, P.F.; Tavares, D.C.; et al. Chemical composition and in vitro schistosomicidal activity of the essential oil of Plectranthus neochilus grown in Southeast Brazil. Chem. Biodivers. 2011, 8, 2149-2157.
8. Moraes, J.; Almeida, A.A.; Brito, M.R.; Marques, T.H.; Lima, T.C.; Sousa, D.P.; Nakano, E.; Mendonca, R.Z.; Freitas, R.M. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni. Planta Med. 2013, 79, 253-258.
9. Porto, T.S.; da Silva Filho, A.A.; Magalhaes, L.G.; dos Santos, R.A.; Furtado, N.A.; Arakawa, N.S.; Said, S.; de Oliveira, D.C.; Gregorio, L.E.; Rodrigues, V.; et al. Fungal transformation and schistosomicidal effects of pimaradienoic acid. Chem. Biodivers. 2012, 9, 1465-1474.
10. Ndjonka, D.; Rapado, L.N.; Silber, A.M.; Liebau, E.; Wrenger, C. Natural Products as a Source for Treating Neglected Parasitic Diseases. Int. J. Mol. Sci. 2013, 14, 3395-3439.
11. Jao, S.C.; Chen, J.; Yang, K.; Li, W.S. Design of potent inhibitors for Schistosoma japonica glutathione S-transferase. Bioorg. Med. Chem. 2006, 14, 304-318.
12. Rai, G.; Sayed, A.A.; Lea, W.A.; Luecke, H.F.; Chakrapani, H.; Prast-Nielsen, S.; Jadhav, A.; Leister, W.; Shen, M.; Inglese, J.; et al. Structure Mechanism Insights and the Role of Nitric Oxide Donation Guide the Development of Oxadiazole-2-Oxides as Therapeutic Agents against Schistosomiasis. J. Med. Chem. 2009, 52, 6474-6483.
13. Rai, G.; Thomas, C.J.; Leister, W.; Maloney, D.J. Synthesis of oxadiazole-2-oxide analogues as potential antischistosomal agents. Tetrahedron Lett. 2009, 50, 1710-1713.
14. Sayed, A.A.; Simeonov, A.; Thomas, C.J.; Inglese, J.; Austin, C.P.; Williams, D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. J. Nat. Med. 2008, 14, 407-412.
15. Liu, J.; Dyer, D.; Wang, J.; Wang, S.; Du, X.; Xu, B.; Zhang, H.; Wang, X.; Hu, W. 3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds. PLoS One 2013, 8, e64984.
16. Domling, A.; Khoury, K. Praziquantel and schistosomiasis. Chemmedchem 2010, 5, 1420-1434.
17. Woelfle, M.; Seerden, J.P.; de Gooijer, J.; Pouwer, K.; Olliaro, P.; Todd, M.H. Resolution of praziquantel. PLoS. Negl. Trop. Dis. 2011, 5, e1260.
18. Meyer, T.; Sekljic, H.; Fuchs, S.; Bothe, H.; Schollmeyer, D.; Miculka, C. Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl. Trop. Dis. 2009, 3, e357.
19. Cao, H.; Liu, H.; Domling, A. Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel. Chemistry 2010, 16, 12296-12298.
20. Liu, H.; William, S.; Herdtweck, E.; Botros, S.; Domling, A. MCR synthesis of praziquantel derivatives. Chem. Biol. Drug. Des. 2012, 79, 470-477.
21. Andrews, P.; Thomas, H.; Pohlke, R.; Seubert, J. Praziquantel. Med. Res. Rev. 1983, 3, 147-200.
22. Patra, M.; Ingram, K.; Pierroz, V.; Ferrari, S.; Spingler, B.; Keiser, J.; Gasser, G. Ferrocenyl derivatives of the anthelmintic praziquantel: Design, synthesis, and biological evaluation. J. Med. Chem. 2012, 55, 8790-8798.
23. Dong, Y.X.; Chollet, J.; Vargas, M.; Mansour, N.R.; Bickle, Q.; Alnouti, Y.; Huang, J.G.; Keiser, J.; Vennerstrom, J.L. Praziquantel analogs with activity against juvenile Schistosoma mansoni. Bioorg. Med. Chem. Lett. 2010, 20, 2481-2484.
24. Patra, M.; Ingram, K.; Pierroz, V.; Ferrari, S.; Spingler, B.; Gasser, R.B.; Keiser, J.; Gasser, G. [(eta(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity. Chemistry 2013, 19, 2232-2235.
25. Ronketti, F.; Ramana, A.V.; Chao-Ming, X.; Pica-Mattoccia, L.; Cioli, D.; Todd, M.H. Praziquantel derivatives I: Modification of the aromatic ring. Bioorg. Med. Chem. Lett. 2007, 17, 4154-4157.
26. Duan, W.W.; Qiu, S.J.; Zhao, Y.; Sun, H.; Qiao, C.; Xia, C.M. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum. Bioorg. Med. Chem. Lett. 2012, 22, 1587-1590.
27. Wang, Z.X.; Chen, J.L.; Qiao, C. Praziquantel Derivatives with Anti-Schistosomal Activity: Aromatic ring Modification. Chem. Biol. Drug. Des. 2013, 82, 216-225.
28. Sadhu, P.S.; Kumar, S.N.; Chandrasekharam, M.; Pica-Mattoccia, L.; Cioli, D.; Rao, V.J. Synthesis of new praziquantel analogues: Potential candidates for the treatment of schistosomiasis. Bioorg. Med. Chem. Lett. 2012, 22, 1103-1106.
29. Frehel, D.; Maffrand, J.P. Synthesis of the new tricyclic system thieno[3',2':3,4]pyrido[1,2-a]pyrazin-4-one. Heterocycles 1984, 22, 143-149.
30. Todd, M.H.; Ndubaku, C.; Bartlett, P.A. Amino acid derived heterocycles: Lewis acid catalyzed and radical cyclizations from peptide acetals. J. Org. Chem. 2002, 67, 3985-3988.
31. Bissinger, E.M.; Heinke, R.; Spannhoff, A.; Eberlin, A.; Metzger, E.; Cura, V.; Hassenboehler, P.; Cavarelli, J.; Schule, R.; Bedford, M.T.; et al. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorg. Med. Chem. 2011, 19, 3717-3731.
32. Kim, D.J.; Reddy, K.; Kim, M.O.; Li, Y.; Nadas, J.; Cho, Y.Y.; Kim, J.E.; Shim, J.H.; Song, N.R.; Carper, A.; et al. (3-Chloroacetyl)-indole, a Novel allosteric AKT inhibitor, Suppresses colon cancer growth in vitro and in vivo. Cancer Prev. Res. 2011, 4, 1842-1851.
33. Nam, K.N.; Koketsu, M.; Lee, E.H. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappa B inhibition. Eur. J. Pharmacol. 2008, 589, 53-57.
34. Dezube, B.J.; Von Roenn, J.H.; Holden-Wiltse, J.; Cheung, T.W.; Remick, S.C.; Cooley, T.P.; Moore, J.; Sommadossi, J.P.; Shriver, S.L.; Suckow, C.W.; et al. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group Study. J. Clin. Oncol. 1998, 16, 1444-1449.
35. Kruger, E.A.; Figg, W.D. TNP-470: An Angiogenesis inhibitor in clinical development for cancer. Expert Opin. Invest. Drug 2000, 9, 1383-1396.
36. Song, L.J.; Li, J.H.; Xie, S.Y.; Qian, C.Y.; Wang, J.; Zhang, W.; Yin, X.R.; Hua, Z.C.; Yu, C.X. Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum. PLoS One 2012, 7, e31456.